Last reviewed · How we verify
Sabin Strain Inactivated Poliovirus Vaccine — Competitive Intelligence Brief
phase 3
Immunology
Biologic
Live · refreshed every 30 min
Target snapshot
Sabin Strain Inactivated Poliovirus Vaccine (Sabin Strain Inactivated Poliovirus Vaccine) — Sinovac Biotech Co., Ltd. The Sabin Strain Inactivated Poliovirus Vaccine works by exposing the body to a weakened form of the poliovirus, stimulating an immune response to provide protection against poliovirus infection.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Sabin Strain Inactivated Poliovirus Vaccine TARGET | Sabin Strain Inactivated Poliovirus Vaccine | Sinovac Biotech Co., Ltd | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Sabin Strain Inactivated Poliovirus Vaccine CI watch — RSS
- Sabin Strain Inactivated Poliovirus Vaccine CI watch — Atom
- Sabin Strain Inactivated Poliovirus Vaccine CI watch — JSON
- Sabin Strain Inactivated Poliovirus Vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Sabin Strain Inactivated Poliovirus Vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/sabin-strain-inactivated-poliovirus-vaccine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab